NO2025048I1 - Ferric citrate coordination complex - Google Patents

Ferric citrate coordination complex

Info

Publication number
NO2025048I1
NO2025048I1 NO2025048C NO2025048C NO2025048I1 NO 2025048 I1 NO2025048 I1 NO 2025048I1 NO 2025048 C NO2025048 C NO 2025048C NO 2025048 C NO2025048 C NO 2025048C NO 2025048 I1 NO2025048 I1 NO 2025048I1
Authority
NO
Norway
Prior art keywords
ferric citrate
coordination complex
citrate coordination
ferric
complex
Prior art date
Application number
NO2025048C
Other languages
English (en)
Norwegian (no)
Original Assignee
Keryx Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keryx Biopharmaceuticals Inc filed Critical Keryx Biopharmaceuticals Inc
Publication of NO2025048I1 publication Critical patent/NO2025048I1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/295Iron group metal compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO2025048C 2012-06-21 2025-11-06 Ferric citrate coordination complex NO2025048I1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261662565P 2012-06-21 2012-06-21
US201361757229P 2013-01-28 2013-01-28
US201361800618P 2013-03-15 2013-03-15
US201361801050P 2013-03-15 2013-03-15

Publications (1)

Publication Number Publication Date
NO2025048I1 true NO2025048I1 (no) 2025-11-06

Family

ID=49769729

Family Applications (1)

Application Number Title Priority Date Filing Date
NO2025048C NO2025048I1 (no) 2012-06-21 2025-11-06 Ferric citrate coordination complex

Country Status (19)

Country Link
US (3) US20130345303A1 (https=)
EP (3) EP3730136B1 (https=)
JP (4) JP2015535209A (https=)
KR (2) KR20200103855A (https=)
CN (2) CN113244209A (https=)
AU (2) AU2013278000A1 (https=)
BR (1) BR112014032049A2 (https=)
CA (1) CA2876982A1 (https=)
DK (1) DK3730136T3 (https=)
EA (1) EA201590062A1 (https=)
ES (2) ES2796254T3 (https=)
FR (1) FR25C1043I1 (https=)
HK (1) HK1214503A1 (https=)
IL (1) IL236356A0 (https=)
MX (1) MX2014015615A (https=)
NO (1) NO2025048I1 (https=)
PL (1) PL3730136T3 (https=)
SG (2) SG11201408521WA (https=)
WO (1) WO2013192565A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108938585A (zh) 2009-07-21 2018-12-07 凯克斯生物制药公司 柠檬酸铁剂型
TWI653043B (zh) * 2012-12-20 2019-03-11 瑞士商伊蘭科動物健康公司 新用途
SI3287133T1 (sl) 2013-06-05 2019-09-30 Tricida Inc. Polimeri, ki vežejo protone,za peroralno dajanje
ES2856261T3 (es) * 2013-10-01 2021-09-27 Fresenius Medical Care Deutschland Gmbh Método y aparatos para determinar una pérdida diaria de hierro de un paciente
HK1223031A1 (zh) * 2013-11-04 2017-07-21 凯克斯生物制药公司 用於降低慢性肾病患者的心力衰竭的枸橼酸铁
WO2015110968A1 (en) * 2014-01-23 2015-07-30 Lupin Limited Pharmaceutical grade ferric citrate and method for its production
EP3157516A4 (en) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
LT3229816T (lt) 2014-12-10 2020-05-25 Tricida Inc. Protoną prijungiantys polimerai, skirti peroraliniam įvedimui
US20180071243A1 (en) * 2015-03-04 2018-03-15 Keryx Biopharmaceuticals, Inc. Use of ferric citrate in the treatment of iron-deficiency anemia
CN104688706B (zh) * 2015-04-01 2017-07-14 成都欣捷高新技术开发有限公司 一种高载药量、快速溶出的枸橼酸铁组合物及其制备方法
WO2016162794A1 (en) * 2015-04-08 2016-10-13 Leiutis Pharmaceuticals Pvt Ltd Pharmaceutical compositions of ferric citrate
WO2016162888A1 (en) * 2015-04-09 2016-10-13 Actavis Group Ptc Ehf. Process for preparing pharmaceutical grade ferric citrate
WO2017193024A1 (en) 2016-05-06 2017-11-09 Tricida, Inc. Hcl-binding compositions for and method of treating acid-base disorders
US20210085711A1 (en) 2017-09-19 2021-03-25 Japan Tobacco Inc. Use of ferric citrate in prevention and/or treatment of iron-deficiency anemia in hypermenorrhea patient and/or patient suffering from hypermenorrhea-associated gynecologic disease
IL319146A (en) 2017-11-03 2025-04-01 Tricida Inc Compositions for and method of treating acid-base disorders
WO2019236639A1 (en) * 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders
JP2022505697A (ja) 2018-10-29 2022-01-14 ファーマコスモス ホールディング エー/エス カルボキシマルトース第二鉄による鉄欠乏症の治療
WO2022150623A1 (en) 2021-01-08 2022-07-14 Akebia Therapeutics, Inc. Compounds and composition for the treatment of anemia
CN117999069A (zh) 2021-05-27 2024-05-07 凯克斯生物制药公司 柠檬酸铁的儿科调配物
CN115024495B (zh) * 2022-06-27 2024-03-22 北京金康普食品科技有限公司 改善肾病患者钙磷代谢的营养组合物及其应用
WO2025181559A1 (en) * 2024-02-29 2025-09-04 Sloiron, Inc. Methods for determining the amount of encapsulated and free iron in a sample

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0922461A4 (en) * 1996-07-19 2002-07-17 Nikken Chemicals Co Ltd MEDICINE AGAINST HYPERPHOSPHATANEMIA
US5753706A (en) * 1996-12-16 1998-05-19 Hsu; Chen Hsing Methods for treating renal failure
US8093423B2 (en) 2003-02-19 2012-01-10 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
CN1600302A (zh) * 2003-09-22 2005-03-30 宝龄富锦生技股份有限公司 含有柠檬酸铁的医药组合物以及药用级柠檬酸铁及其制法和含有药用级柠檬酸铁的膳食营养品
US20060134227A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
NZ566743A (en) 2005-08-18 2010-07-30 Globoasia Llc Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
EP1973549B1 (en) * 2006-01-06 2016-07-20 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron
EP3066923B1 (en) * 2006-01-30 2025-11-05 Panion & BF Biotech Inc. Method of treating chronic kidney disease
CN108938585A (zh) * 2009-07-21 2018-12-07 凯克斯生物制药公司 柠檬酸铁剂型

Also Published As

Publication number Publication date
ES2796254T3 (es) 2020-11-26
EP3730136B1 (en) 2023-12-27
EP4335436A3 (en) 2024-05-15
US20140234416A1 (en) 2014-08-21
HK1214503A1 (zh) 2016-07-29
JP2015535209A (ja) 2015-12-10
EP2863906B1 (en) 2020-03-18
EP4335436A2 (en) 2024-03-13
IL236356A0 (en) 2015-02-26
CN113244209A (zh) 2021-08-13
WO2013192565A2 (en) 2013-12-27
AU2018203205B2 (en) 2020-03-12
KR20200103855A (ko) 2020-09-02
MX2014015615A (es) 2015-03-20
US20150079168A1 (en) 2015-03-19
JP2020100638A (ja) 2020-07-02
HK1210013A1 (en) 2016-04-15
SG10201805177PA (en) 2018-07-30
BR112014032049A2 (pt) 2017-07-25
JP2022070945A (ja) 2022-05-13
AU2013278000A1 (en) 2015-01-22
CA2876982A1 (en) 2013-12-27
US20130345303A1 (en) 2013-12-26
PL3730136T3 (pl) 2024-03-25
DK3730136T3 (da) 2024-01-22
KR102150135B1 (ko) 2020-08-31
EP2863906A2 (en) 2015-04-29
ES2970050T3 (es) 2024-05-24
AU2018203205A1 (en) 2018-05-31
EA201590062A1 (ru) 2016-02-29
EP3730136A1 (en) 2020-10-28
WO2013192565A3 (en) 2015-10-15
JP2018138562A (ja) 2018-09-06
CN104884055A (zh) 2015-09-02
FR25C1043I1 (fr) 2026-01-02
KR20150036131A (ko) 2015-04-07
SG11201408521WA (en) 2015-01-29

Similar Documents

Publication Publication Date Title
NO2025048I1 (no) Ferric citrate coordination complex
EP2921192A4 (en) CATHETER
JP2012236821A5 (ja) 有機金属錯体
LT2903991T (lt) Antifibroziniai piridinonai
EP2823767A4 (en) CATHETER
DK3248490T3 (da) Benbeklædningsgenstand
BR112014029111A2 (pt) inalador
GB201208309D0 (en) Complexes
EP2934454C0 (en) Anti-dandruff composition
UA24760S (uk) Шрифт
EP2926857A4 (en) Catheter
EP2888271A4 (en) METAL COMPLEX
EP2826516A4 (en) GUIDE WIRE
LT2849760T (lt) Oligonukleotidų chelatinių kompleksų būdai
DK2936399T3 (da) Tæller
DE112013004610A5 (de) Metallkomplexe
EP2810680A4 (en) CATHETER
EP2810682A4 (en) GUIDE WIRE
FI9621U1 (fi) Lomamökki
UA25745S (uk) Зупинковий комплекс
FR2997629B1 (fr) Catheter
TH1301007279B (th) ซิปเลื่อน
BR302012006400S1 (pt) Configuração aplicada em carrinho conversível
ES1077199Y (es) Vestido
GB201210358D0 (en) Complexes